During the past decade, University of Michigan Medical School conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 6 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Michigan Medical School" #1 sponsor was "University of Michigan" with 10 trials, followed by "American Medical Systems" with 1 trials sponsored, "Chimerix" with 1 trials sponsored, "Dana-Farber Cancer Institute" with 1 trials sponsored and "Edwards Lifesciences" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Michigan Medical School" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Donaghue Medical Research Foundation" with 1 trials as a collaborator, "Emory University" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "University of Michigan Medical School" are "Delirium" (2 trials), "Depression" (2 trials), "Advanced or Metastatic Solid Tumors" (1 trials), "Anaplastic Thyroid Cancer" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "University of Michigan Medical School" in a lesser frequency.

Most popular intervention types in "University of Michigan Medical School" are "Drug" (9 trials), "Behavioral" (4 trials), "Biological" (4 trials), "Other" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "AMS 700 IPP with MS Pump" (1 trials), "Anthracycline" (1 trials), "Azacitidine" (1 trials) and "Brincidofovir" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Michigan Medical School" are 20 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Michigan Medical School". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 15 completed trials in University of Michigan Medical School, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Michigan Medical School, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".